NMR (NMR) Stock Price & Analysis
NMR (NMR) rose 1.52% to USD 8.71 as of June 10, 2026 at 00:42 UTC, according to Nexqual real-time market data.
NMR last closed at USD 8.58; the session ranged USD 8.55–8.87 on volume of 2,085,467 shares. Market capitalization is $25.46B, with a 52-week range of USD 6.02–9.58 (NYQ). Source: Nexqual, June 10, 2026 at 00:42 UTC.
Key Statistics (as of June 10, 2026 at 00:42 UTC)
| Price | USD 8.71 |
|---|---|
| Change | ▲ 1.52% (up) |
| Previous Close | USD 8.58 |
| Open | USD 8.8 |
| Day Range | USD 8.55 – 8.87 |
| 52-Week Range | USD 6.02 – 9.58 |
| Volume | 2,085,467 shares |
| Market Cap | $25.46B |
| Exchange | NYQ |
Technical Analysis (NMR)
Nexqual's technical model rates NMR "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 00:42 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 62.75 (neutral) |
| vs SMA50 | Above (USD 8.16) |
| MACD | 0.13 (positive) |
Analyst Ratings (NMR)
Wall Street analysts rate NMR "None" based on 1 analysts, with a mean price target of USD 9.35 (range USD 9.35–9.35), per Nexqual as of June 10, 2026 at 00:42 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 9.35 |
| High Target | USD 9.35 |
| Low Target | USD 9.35 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (NMR)
| Next Earnings Date | 2026-04-24 |
|---|---|
| Revenue Estimate | $560.18B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.16 vs est 0.21 ▼ miss |
| 2025-12-31 | USD 0.2 vs est 0.24 ▼ miss |
| 2025-09-30 | USD 0.2 vs est 0.17 ▲ beat |
| 2025-06-30 | USD 0.24 vs est 0.25 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:42 UTC.
Financials & Fundamentals (NMR)
| Total Revenue | $2.17T |
|---|---|
| Revenue Growth (YoY) | +27.50% |
| Gross Margin | +78.31% |
| Operating Margin | +18.66% |
| Profit Margin | +16.71% |
| ROE | +10.07% |
| Debt / Equity | 917.37 |
| Current Ratio | 1.58 |
| Total Cash | $48.62T |
| Total Debt | $35.36T |
Source: Nexqual, June 10, 2026 at 00:42 UTC.
Financial Health Score (NMR)
Nexqual rates NMR's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:42 UTC.
| Growth | Solid — Revenue +15% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 78%, operating 19% |
| Balance Sheet | Critical — $48.62T cash vs $35.36T debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$843.0B |
| Efficiency | Mixed — ROE 10%, ROA 0.6% |
Ownership (NMR)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +3.08% |
| Shares Outstanding | 2.92B |
| Float | 2.73B |
| Short % of Float | +0.07% |
Source: Nexqual, June 10, 2026 at 00:42 UTC.
Leadership (NMR)
NMR is led by Kentaro Okuda (age 62), President, Group CEO, Representative Executive Officer & Director, per Nexqual as of June 10, 2026 at 00:42 UTC.
| President, Group CEO, Representative Executive Officer & Director | Kentaro Okuda (age 62) |
|---|---|
| Chief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | Toshiyasu Iiyama (age 60) |
| Representative Executive Officer, Deputy President & Director | Yutaka Nakajima (age 60) |
| Executive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | Christopher Paul Willcox (age 57) |
| Executive Officer & CFO | Hiroyuki Moriuchi (age 49) |
Major Backers & Investors (NMR)
Notable institutional backers of NMR include Donald Smith & Co., Inc., Fisher Asset Management, LLC, Morgan Stanley, according to Nexqual as of June 10, 2026 at 00:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Donald Smith & Co., Inc. | 0.43% |
| Fisher Asset Management, LLC | 0.42% |
| Morgan Stanley | 0.34% |
| Goldman Sachs | 0.18% |
| FMR, LLC | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.18% |
| Dimensional Fund Advisors | 0.18% |
| Vanguard Group | 0.15% |
Source: Nexqual, June 10, 2026 at 00:42 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MFG | Mizuho Financial Group, Inc. Sp | USD 9.57 | ▲ 0.53% |
| IX | ORIX Corporation | USD 38.9 | ▲ 2.69% |
| SMFG | Sumitomo Mitsui Financial Group | USD 23.07 | ▼ 0.39% |
| MUFG | Mitsubishi UFJ Financial Group, | USD 19.83 | ▼ 0.4% |
| KB | KB Financial Group Inc | USD 102.25 | ▼ 5.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:42 UTC. This page is informational and not investment advice.